Impact BioMedical, Inc. (IBO)
0.489
+0.03
(+6.77%)
USD |
NYAM |
Sep 02, 16:00
0.489
0.00 (0.00%)
After-Hours: 20:00
Impact BioMedical Cash from Investing (Quarterly) : 0.002M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.002M |
| March 31, 2026 | -0.001M |
| December 31, 2025 | 0.001M |
| September 30, 2025 | 0.001M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.001M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.001M |
| June 30, 2024 | 0.001M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.001M |
| September 30, 2023 | -0.001M |
| Date | Value |
|---|---|
| June 30, 2023 | -0.011M |
| March 31, 2023 | -0.004M |
| December 31, 2022 | -0.275M |
| September 30, 2022 | -0.001M |
| June 30, 2022 | 0.032M |
| March 31, 2022 | -0.105M |
| December 31, 2021 | -0.944M |
| September 30, 2021 | -2.389M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.6321M |
| September 30, 2020 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | 0.00 |
| LENZ Therapeutics, Inc. | 37.75M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.47M |
| Cash from Financing (Quarterly) | -0.482M |
| Free Cash Flow | -0.508M |
| Free Cash Flow Per Share (Quarterly) | 0.0044 |
| Free Cash Flow to Equity (Quarterly) | 0.47M |
| Free Cash Flow to Firm (Quarterly) | 0.47M |
| Free Cash Flow Yield | -1.25% |